According to Kymera Therapeutics's latest financial reports the company's current revenue (TTM) is $78.59 M. In 2022 the company made a revenue of $46.82 M a decrease over the years 2021 revenue that were of $72.83 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $78.59 M | 67.84% |
2022 | $46.82 M | -35.71% |
2021 | $72.83 M | 114% |
2020 | $34.03 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |